2014, Number 2
<< Back Next >>
Ann Hepatol 2014; 13 (2)
Is recurrence rate of incidental hepatocellular carcinoma after liver transplantation similar to previously known HCC? Towards a predictive recurrence score
Piñero F, Mendizabal M, Casciato P, Galdame O, Quiros R, Bandi J, Mullen E, Andriani O, de Santibañes E, Podestá LG, Gadano A, Silva M
Language: English
References: 25
Page: 211-218
PDF size: 113.98 Kb.
ABSTRACT
Background. Incidental hepatocellular carcinoma (iHCC) generates uncertainty over risk of recurrence after liver transplantation (LT).
Aim. To compare recurrence between iHCC and confirmed HCC diagnosed prior to transplant based on imaging criteria (cHCC).
Material and methods. Fifty-four HCC patients were
analyzed from a series of 309 consecutive adult transplanted patients. We developed a recurrence predicting score (RPS) applying ORs based on pathologic risk variables.
Results. Incidence of iHCC was 4.8%
(n = 15) and overall recurrence 12.9% (cHCC 15.4% and iHCC 7%; P = 0.39). Variables included in the RPS
were: microvascular invasion OR 17.8 (1.78-178.97; P = 0.014: 2 points), neural invasion OR 15.5 (1.13-212.17;
P = 0.04: 1.5 points), nuclear grade › II OR 9.3 (1.17-74.84; P = 0.035: 1 point), and beyond Up-to 7 criteria OR 13.1 (1.66-103.67; P = 0.015: 1.5 points). Two risk groups were identified: low risk for recurrence (0-1 point) and intermediate-high risk groups (2-6 points). Low risk category remained an independent predictor of recurrence: OR 0.11 (0.01-0.67; P = 0.017); AUROC of 0.75 (0.54-0.96). A tendency towards more patients categorized as low risk group among iHCC patients was observed (69.2%; P = 0.13).
Conclusions. In this series iHCC was not associated to lower risk of recurrence when compared to cHCC. We propose application of an RPS as a clinical tool for recurrence risk estimation.
REFERENCES
Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Wiesner R, et al. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transplantation 2004; 10: 36-41.
Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010; 30: 003-016.
Mazzaferro VV, Regalia EE, Doci RR, Andreola SS, Pulvirenti AA, Bozzetti FF, Gennari L, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience. Liver Transplantation 2011; 17: S44-S57.
Shin WY, Suh K-S, Lee HW, Kim J, Kim T, Yi N-J, Lee KU. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 2010; 16: 678-84.
Cescon M, Ravaioli M, Grazi GL, Ercolani G, Cucchetti A, Bertuzzo V, Pinna AD, et al. Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant 2010; 2010: 1-8.
Cho CS, Knechtle SJ, Heisey DM, Hermina M, Armbrust M, D’Alessandro AM, Kalayoglu M, et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 2001; 5: 594-602.
Hwang S, Ahn C-S, Kim K-H, Moon D-B, Ha T-Y, Song G-W, Lee SG, et al. Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation. J Gastrointest Surg 2011; 15: 971-81.
Raphe R, Felício HCC, Rocha MF, Duca WJ, Arroyo PC Jr, D’SantiNeto D, da Silva RF, et al. Histopathologic characteristics of incidental hepatocellular carcinoma after liver transplantation. Transplantation Proceedings 2010; 42: 505-6.
Castillo E, Pelletier S, Kumer S, Abouljoud M, Divine G, Moonka D. Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes. Transplantation Proceedings 2009; 41: 219-21.
Sotiropoulos GC, Malag M, Molmenti EP, Nadalin S, Radtke A, Brokalaki EI, Broelsch CE, et al. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation 2006; 81: 531-5.
Choi SH, Lee HH, Lee DS, Choi JH, Heo JS, Lee KW, Lee SK, et al. Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation. Transplantation Proceedings 2004; 36: 2293-4.
Charco R, Hidalgo E, Lázaro JL, Vargas V, Castells L, Murio E, Margarit C, et al. Outcome of cirrhotic patients with incidental hepatocellular carcinoma undergoing liver transplantation. Transplantation Proceedings 2002; 34: 299-300.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
Yao FY. Liver Transplantation for hepatocellular carcinoma: beyond the Milan Criteria. Am J Transplant 2008; 8: 1982-9.
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Roberts JP, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-403.
Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation 2002; 8: 765-74.
Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplantation 2004; 10: 534-40.
Chan EY, Larson AM, Fix OK, Yeh MM, Levy AE, Bakthavatsalam R, Perkins JD, et al. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies. Liver Transplantation 2008; 14: 956-65.
Parfitt JR, Marotta P, AlGhamdi M, Wall W, Khakhar A, Suskin NG, Driman DK, et al. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence. Liver Transplantation 2007; 13: 543-51.
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Majno P, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncology 2009; 10: 35-43.
D’Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Cilo U, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transplantation 2009; 15: 1278-87.
Chui AKK, Wong J, Rao ARN, Ng SSM, Chan FKL, Chan HLY, Lau WY, et al. High incidence of incidental hepatocellular carcinoma exists among hepatitic explanted livers. Transplantation Proceedings 2003; 35: 350-1.
Edmondson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 1: 462-503.
Sistema Nacional de Información de Procuración y Trasplante de la República Argentina. SINTRA, I.C.U.C.A.I. Available from: www.incucai.gov.ar.